Australia News Beep | NewsBeep.com
  • News Beep
  • Australia
  • Headlines
  • Business
  • Entertainment
  • Health
  • Science
  • Sports
  • Technology
Australia News Beep | NewsBeep.com
Australia News Beep | NewsBeep.com
  • News Beep
  • Australia
  • Headlines
  • Business
  • Entertainment
  • Health
  • Science
  • Sports
  • Technology

Browsing Tag

Medical Pharmaceuticals

18 posts
HHealthcare
Lilly to acquire AtaiBeckley to advance therapies for treatment-resistant depression and other mental health conditions
Read More

Lilly to acquire AtaiBeckley to advance therapies for treatment-resistant depression and other mental health conditions

  • July 18, 2026
AtaiBeckley’s lead program, BPL-003, is designed to provide durable relief from treatment-resistant depression Acquisition expands Lilly’s neuroscience pipeline…
HHealthcare
Septa Pharmaceuticals Inc. Acquires CeeNU® (Lomustine) from Bristol Myers Squibb, Canada
Read More

Septa Pharmaceuticals Inc. Acquires CeeNU® (Lomustine) from Bristol Myers Squibb, Canada

  • July 15, 2026
Mississauga, ON, July 15, 2026 /PRNewswire/ – Septa Pharmaceuticals Inc., a rapidly growing leader in the Canadian healthcare…
MMedication
Novo Nordisk Introduces Extra Savings for Canadians Who Choose Ozempic®
Read More

Novo Nordisk Introduces Extra Savings for Canadians Who Choose Ozempic®

  • May 26, 2026
MISSISSAUGA, ON, May 26, 2026 /CNW/ – Novo Nordisk Canada is announcing that effective Friday, May 29, 2026,…
HHealthcare
Vi Launches Suite of AI Agents for Healthcare, Life Sciences, and Wellness Enterprises; Completes $145M Transaction at $1.64B Valuation
Read More

Vi Launches Suite of AI Agents for Healthcare, Life Sciences, and Wellness Enterprises; Completes $145M Transaction at $1.64B Valuation

  • May 20, 2026
NEW YORK, May 19, 2026 /PRNewswire/ — Vi, the enterprise-AI platform for health, today announced a new suite…
HHealthcare
Apotex launches Apo‑Semaglutide Injection™, a generic equivalent of Ozempic®, in Canada
Read More

Apotex launches Apo‑Semaglutide Injection™, a generic equivalent of Ozempic®, in Canada

  • May 15, 2026
TORONTO, May 14, 2026 /PRNewswire/ – Apotex Inc. (“Apotex” or the “Company”), the largest Canadian‑based global health company,…
HHealthcare
Lilly's Kisunla (donanemab) receives marketing authorization by European Commission for the treatment of early symptomatic Alzheimer's disease
Read More

Lilly to acquire Ajax Therapeutics to advance outcomes for patients with myelofibrosis and polycythemia vera

  • May 2, 2026
Ajax’s lead program, AJ1-11095, is a first-in-class Type II JAK2 inhibitor currently in Phase 1 clinical development, with…
HHealthcare
Zimmer Biomet Appoints Dr. Jonathan M. Vigdorchik as Chief Science, Technology and Medical Affairs Officer
Read More

Zimmer Biomet Appoints Dr. Jonathan M. Vigdorchik as Chief Science, Technology and Medical Affairs Officer

  • April 7, 2026
Experienced orthopedic surgeon from the Hospital for Special Surgery, innovator and former Chief Medical Technology Advisor joins company…
HHealthcare
Illumina and MyOme Strike Collaboration Deal Including Strategic Investment to Support MyOme's Clinical Trial That Could Save U.S. Healthcare $200 Billion Annually
Read More

Illumina and MyOme Strike Collaboration Deal Including Strategic Investment to Support MyOme’s Clinical Trial That Could Save U.S. Healthcare $200 Billion Annually

  • December 12, 2025
Partnership unites Illumina’s leading sequencing technology with cutting-edge clinical genomics analyses and AI to advance precision medicine for…
HHealthcare
Lin Health Raises $11 Million Series A to Fuel Growth of Virtual Chronic Pain Recovery Platform
Read More

Lin Health Raises $11 Million Series A to Fuel Growth of Virtual Chronic Pain Recovery Platform

  • December 10, 2025
Oversubscribed round demonstrates strong investor confidence in Lin Health’s neuroscience-based approach to chronic pain DENVER, Dec. 9, 2025…
HHealthcare
FDA Issues Formal Guideline Waiving Clinical Efficacy Studies for Biosimilars, Confirming Professor Niazi's 15-Year Campaign to Cut Biologic Drug Costs
Read More

FDA Issues Formal Guideline Waiving Clinical Efficacy Studies for Biosimilars, Confirming Professor Niazi’s 15-Year Campaign to Cut Biologic Drug Costs

  • October 30, 2025
A Landmark Regulatory Shift Validates Professor Sarfaraz K. Niazi’s Vision to Make Biologics as Affordable as Generics CHICAGO,…
HHealthcare
Lilly's Kisunla (donanemab) receives marketing authorization by European Commission for the treatment of early symptomatic Alzheimer's disease
Read More

Lilly’s Kisunla (donanemab) receives marketing authorization by European Commission for the treatment of early symptomatic Alzheimer’s disease

  • September 27, 2025
Approved for earliest symptomatic stages of disease, demonstrating significant slowing of cognitive and functional decline Only therapy with…
HHealth
Study Reveals How Tick-Borne Encephalitis Virus Enters Cells
Read More

Study Reveals How Tick-Borne Encephalitis Virus Enters Cells

  • September 24, 2025
A Cell-Surface Protein Provides Key to Infection BRONX, N.Y., Sept. 24, 2025 /PRNewswire/ — The protein on human cells…
Australia News Beep | NewsBeep.com
www.newsbeep.com